RxDoctor Payments Data

William Rowland, MD

Family Medicine · Boca Raton, FLNPI 1639270200

Payments from drug & device makers

$6,351in general payments, 2019–2025

Across 358 payments — averaging $17.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$808
  • Amgen$741
  • Novo Nordisk$670
  • Pfizer$536
  • AstraZeneca$448
  • GSK$347
  • plus $3K from 45 others

What the payments were for

  • Food & beverage$6,345100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,351 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$454,011
Medicare patients
985
Services billed
5,670

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban183$171,632
TrulicityDulaglutide71$94,570
MounjaroTirzepatide43$70,728
XareltoRivaroxaban51$63,148
OzempicSemaglutide46$54,167
JardianceEmpagliflozin43$54,130
FarxigaDapagliflozin Propanediol44$47,863
EntrestoSacubitril/Valsartan12$13,144
MyrbetriqMirabegron14$11,334
Rosuvastatin Calcium736$8,049
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,267
Atorvastatin Calcium824$6,168
Levothyroxine Sodium608$5,673
SynthroidLevothyroxine Sodium65$5,121
Amlodipine Besylate852$4,905

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$536$171,632183 claims
Lilly USA, LLCTrulicity, Mounjaro$808$165,299114 claims
Johnson & JohnsonXarelto$96$63,14851 claims
Novo NordiskOzempic$670$54,16746 claims
Boehringer IngelheimJardiance$261$54,13043 claims
AstraZenecaFarxiga$448$47,86344 claims
NovartisEntresto$210$13,14412 claims
Astellas Pharma US IncMyrbetriq$61$11,33414 claims
GSKTrelegy Ellipta$347$7,26711 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$12$5,673608 claims
AbbVieSynthroid$324$5,12165 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Boca Raton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →